Skip to content
OpenCapital
Get started

GeneDx Holdings WGS Enterprise value

Enterprise value at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$27.5B+49.9%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$7.64B-6.9%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$27.54B+9.5%
Revvity logo
RevvityRVTY
$12.88B-13.7%
Labcorp Holdings logo
Labcorp HoldingsLH
$28.24B+10.2%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$1.72B-24.3%
P/S3.9×-3.0×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%—
Net margin-17.6%—
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%—
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

$1.9Bmarket cap+$96.7Mtotal debt−$94.9Mcash and equivalents=$1.88B

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GeneDx Holdings's enterprise value?
GeneDx Holdings (WGS) reported enterprise value of $1.88B in Q1 2026.
How has GeneDx Holdings's enterprise value changed year-over-year?
GeneDx Holdings's enterprise value decreased by 22.8% year-over-year, from $2.44B to $1.88B.
What is the long-term trend for GeneDx Holdings's enterprise value?
Over 4 years (2021 to 2025), GeneDx Holdings's enterprise value has grown at a -42.8% compound annual growth rate (CAGR), from $35.17B to $3.77B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.